The Global Amitriptyline Market Growth Is Accelerated By Rising Consumption

Amitriptyline Market
 

 Amitriptyline is a tricyclic antidepressant used to treat depression and neuropathic pain. It helps restore the balance of certain natural chemicals in the brain like serotonin and norepinephrine.

The global Amitriptyline Market is estimated to be valued at US$ 699.27 Mn in 2024 and is expected to exhibit a CAGR of 5.1% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The consumption of amitriptyline has been rising globally owing to the increasing prevalence of depression and neuropathic pain disorders. According to WHO, depression is now the leading cause of ill health and disability worldwide. Nearly 280 million people are living with depression. The increasing cases of depression and chronic pain disorders have been the major factor driving the growth of the amitriptyline market. Besides this, amitriptyline is considered as the first line treatment option for neuropathic pain conditions like diabetic neuropathy and post-herpetic neuralgia. This has further augmented the demand for amitriptyline over the forecast period.


Segment Analysis
The global Amitriptyline market is dominated by the depression segment. Amitriptyline is commonly prescribed for major depressive disorder as it is proven to be effective for treatment-resistant depression. It helps relieve symptoms such as depressed mood, loss of interest, feelings of guilt or low self-worth, disturbed sleep or appetite, low energy, and poor concentration. This makes depression the largest application segment in the Amitriptyline market.

Key Takeaways
The global Amitriptyline market analysis is expected to witness high growth over the forecast period of 2024 to 2031. The global Amitriptyline Market is estimated to be valued at US$ 699.27 Mn in 2024 and is expected to exhibit a CAGR of 5.1% over the forecast period 2024 to 2031.

Regional analysis:
North America currently dominates the Amitriptyline market and is expected to continue its dominance over the forecast period. High prevalence of depression in countries like the U.S. and rising awareness about available treatment options are major factors contributing to the region's large share. However, Asia Pacific is projected to grow at the fastest pace owing to increasing healthcare expenditure and growing geriatric population in countries like China and India.

Key players:
Key players operating in the Amitriptyline market are Adani Wilmar Ltd., Ruchi Soya Industries Ltd, Associated British Foods plc, Archer Daniels Midland Company, Beidahuang Group, Bunge Limited, Borges Mediterranean Group, Cargill Incorporated, Fuji Vegetable Oil, Inc.

Get more insights on this topic: https://www.newswirestats.com/amitriptyline-market-industry-insights-trends-amitriptyline-market/

Comments

Popular posts from this blog

The Global Coffee Market Growth Accelerated By Demand From Millennials And Gen Z Population

The Global Ammonium Nitrate Market Growth Accelerated By Rising Demand From Agriculture Industry

The Global Biopharmaceuticals Market Growth Accelerated By Innovation In Product Development